The Food and Drug Administration on Thursday approved a drug, 'BiDil' for the treatment of heart failure in African Americans.

According to The Associated Press report, the FDA defended their stance by calling it a step toward "the promise of personalized medicine

Nearly six months after a devastating tsunami left over 200,000 people dead or missing in Asia and Africa, survivors are suffering from unusual lung and sinus infections, and even a paralyzing brain infection.

Reuters reports doctors from Massachusetts General Hospital revealed in the New England Journal of Medicine the case of a 17-year-old girl from Indonesia who was 2.5 kilometers inland when a wave from the Dec. 26 tsunami swept her up and carried her another kilometer

Christina Ficara - All Headline News Staff Reporter

Safura Abdool Karim interviewed 120 of her former schoolmates for a science project about whether they suffered problems after playing computer games

William J Brown - All Headline News Staff

A U.S. Food and Drug Administration advisory panel gave approval Wednesday to the first medicine targeting a specific racial group

Danielle George - All Headline News Staff Reporter

If approved, NitroMed's BiDil would prevent heart failure in blacks. Even with an approval for blacks only, doctors could prescribe BiDil for anyone they thought it might help